Wedgewood expansion design suites m & n
Active Awarded Last action
- Contract number
- 75N91021F00019
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,763,273
Award facts
- Opportunity
-
- NCIOSFM210111 Solicitation number
- Contract value 100% obligated
- $7,763,273.00 Current and potential, with all options
- Completion date 95% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $125,385 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $5,350,970 | |
| Other Administrative Action | $206,489 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $212,232 | |
| Other Administrative Action | $0 | |
| Original award | $1,868,197 |
Show all 13
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 20, 2021, for the Wedgewood Expansion Design Suites M & N project, with a ceiling value of $7.763 million and an ultimate completion date of January 26, 2027.
This is a cost-plus-fixed-fee delivery order against an NCI master indefinite delivery contract. Place of performance is Frederick, Maryland. The order funds design and expansion work for research facilities at the Frederick National Laboratory for Cancer Research campus.
Service Contract Inventory reporting shows actual government-invoiced labor activity across the performance period. FY2025 (the most recent reported year) captured $2.7 million invoiced against 4.9 FTEs and 10,171 contractor hours, with a derived government-paid blended hourly rate of $266.86/hr. FY2024 invoiced $874 thousand across 864 contractor hours at $1,011.24/hr; FY2023 invoiced $535 thousand across 6,858 contractor hours at $78.09/hr; and FY2022 invoiced $810 thousand across 4,570 contractor hours at $177.34/hr. In FY2025, one subcontractor performed 94 percent of reported contractor hours, indicating significant sub-engagement depth for this phase of delivery.
Quick answers
Who was awarded contract 75N91021F00019?
75N91021F00019 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2021.
How much is contract 75N91021F00019 worth?
The government has obligated $7,763,273 on 75N91021F00019.
Is contract 75N91021F00019 an order under another contract?
Yes. 75N91021F00019 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00019 competed?
The extent of competition for 75N91021F00019 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award